Search results
Check Out What Whales Are Doing With AMGN - Amgen (NASDAQ:AMGN)
Benzinga· 6 hours agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Amgen AMGN . And retail traders should know. We noticed this today when the trades ...
Sandoz reaches agreement with Amgen over patent dispute
Reuters· 6 days agoSwiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. denosumab biosimilars.
The Art of Valuation: Discovering Amgen Inc's Intrinsic Value
Guru Focus· 8 hours agoIn this article, we will take a look into Amgen Inc's (AMGN) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of usi
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 3 days agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 2 days agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors ...
Where Is Amgen Headed After the Stock Surges on Obesity Drug News?
TheStreet.com· 3 days agoShares of Amgen (AMGN) are soaring higher Friday morning after the biopharma company's CEO gave a...
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoOpportunities for growth in rare disease treatments and biosimilars market. Regulatory and pricing pressures present ongoing threats to profitability....
Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoAmgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript May 2, 2024 Amgen Inc. beats earnings...
... Company Following Positive Obesity Pipeline Update - ARK Genomic Revolution ETF (BATS:ARKG),...
Benzinga· 1 day agoWhat Happened: Ark, through its ARK Genomic Revolution ETF ARKG, bought 11,360 shares of Amgen, Inc....
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment - Amgen (NASDAQ:AMGN)
Benzinga· 4 days agoAmgen Inc. AMGN reported first-quarter financial results after the closing bell Thursday. The...